Terms and Conditions and Protection of Personal Data



Legal information

This Site https://cushingscommunity.com/ is published by HRA Pharma Rare Diseases SAS, a private limited company with a capital of 1 900 729,65 €, with registered headquarters at 200, avenue de Paris, 92320 Châtillon, France, registered on the Trade and Companies Register under number 438 712 333 R.C.S. Nanterre.

To contact Laboratoire HRA Pharma Rare Diseases, click on the following link: https://www.hra-pharma-rare-diseases.com/contact-us or call +33(0) 01 40 33 93 14. The Site publication director is the legal representative of HRA Pharma Rare Diseases, i.e. Laboratoire HRA Pharma SAS represented by Svend Andersen, CEO.

Laboratoire HRA Pharma Rare Diseases is a ‘Laboratoire pharmaceutique” according to the French Public Health Code, licensed by the ANSM (French health Authority).

The Site content is hosted on servers provided by the company Upwards Group Limited, Calle Rafael Pascual 9, Oliva, Spain.

 

Use of the Site

Access to and use of this site are subject to these Terms of Use and all applicable laws and regulations. By accessing and using this site, you accept, without limitation or qualification, these Terms of Use.

HRA Pharma Rare Diseases reserves the right to change these Terms of Use from time to time without notice, as it deems necessary; you are therefore advised to check them regularly.

Access to this site is not restricted to health care providers. This site is intended for a global audience.

This site is not intended to be used as a source of medical advice or opinion, or to promote drugs and medical devices. Under no circumstances should anything provided on this site be used to establish a medical diagnosis, which can only be achieved by consulting a qualified doctor.

 

Content and Liability

This site was created to provide all audiences worldwide with non-promotional information about Cushing’s syndrome including diagnosis, management, comorbidities. It has been developed in accordance with the principles of European regulations.

You agree that access to and use of this site and the content thereof is at your own risk. HRA Pharma Rare Diseases and any party involved in creating, producing or delivering this site hereby expressly exclude:

All conditions, warranties and other terms that might otherwise be implied by statute, common law or the law of equity.

Any liability for any direct, indirect or consequential loss or damage incurred by any user arising out of access to, use of or inability to use this site, or any errors or omissions in the content thereof.

HRA Pharma Rare Diseases accepts no liability for any loss or damage caused by a denial of distribution service, attack, viruses or other technologically harmful material that may infect your computer equipment, computer programs, data or other proprietary material due to your use of the audio, video, data or text on the site or any other aspect of the site.

 

Protection of Personal Data

HRA Pharma Rare Diseases respects the privacy of its site users, and users should refer to the Privacy Policy for information related to the collection and use of your personal information.

 

Trademarks and Logos

You may not use in any way any of the trademarks and logos used within this site without HRA Pharma Rare Diseases’ authorization.

 

Copyright

HRA Pharma Rare Diseases is the owner or licensee of all copyright in the site. All such rights are reserved.

You may download and retain on your disk or in hard-copy form a single copy of material published on this site only for your personal, non-commercial use, provided that you do not remove any copyright or other proprietary notices. You may not otherwise copy, distribute, display, download, modify, repost, transmit or use all or part of any material without HRA Pharma Rare Diseases’ prior written permission. You may not mirror on another web server all or part of any material published by HRA Pharma Rare Diseases on this site, and you may not copy any of the graphics contained in any material published on this site.

Nothing contained herein shall be construed as conferring by implication, estoppels or otherwise, any license or right under any patent or trademark of HRA Pharma Rare Diseases, or any third party. Except as expressly provided above, nothing contained herein shall be construed as conferring any license or right to any copyright work of which HRA Pharma Rare Diseases is the owner or licensee.

 

Third Party Sites and external links

This site may be used as a portal to other sites. However, links or references to other sites maintained by third parties over whom HRA Pharma Rare Diseases has no control are provided merely as a convenience. Similarly, this site may be accessed from third party links over which HRA Pharma Rare Diseases has no control. HRA Pharma Rare Diseases makes no warranties or representations of any kind as to the accuracy, currency, or completeness of any information contained in such sites and shall have no liability for any loss or damage of any kind that may arise from your use of such content or information. Inclusion of any third party’s link does not imply an endorsement or recommendation by HRA Pharma Rare Diseases.

 

Reservation of Rights

HRA Pharma Rare Diseases reserves the right to alter or delete material from this site at any time without notice.

 

Governing Laws

French laws govern these Terms of Use and their interpretation, and the French courts shall have exclusive jurisdiction to settle any dispute arising out of or in connection with these Terms of Use.

 

Miscellaneous

If any provision of these Terms of Use is held to be unlawful, void or unenforceable, then such provision shall be severable without affecting the validity, lawfulness or enforceability of all remaining provisions.

Except as expressly provided, these Terms of Use constitute the entire agreement between you and HRA Pharma Rare Diseases with respect to the use of this site and content.

 

Last Update April, 2023

An informational resource about Cushing’s Syndrome fully funded as a service to the community by HRA Pharma Rare Diseases
The Cushing's Collaborative Community